Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in pediatric OCD
NCT04673578Phase 2Unknown
- Sponsor
- University of British Columbia
- Start
- Jun 2021
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in obsessive compulsive disorder (OCD), sponsored by University of British Columbia. Status: unknown.
02
Drugs
celecoxib
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT04673578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04673578.